SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences - Quaterly Results

10 Feb 2023 Evaluate
The revenue slipped marginally during the December 2022 quarter. A decline of about Rs. 907.57 millions was observed as compared to Rs. 926.88 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -6.68% to Rs. 40.11  millions from Rs. 42.98 millions.Operating Profit reported a sharp decline to 87.13 millions from 90.07 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 907.57 926.88 -2.08 2496.90 2506.68 -0.39 3456.28 2602.56 32.80
Other Income 5.03 0.26 1834.62 9.34 7.22 29.36 15.36 13.33 15.23
PBIDT 87.13 90.07 -3.26 244.80 246.13 -0.54 329.00 310.68 5.90
Interest 12.59 10.02 25.65 36.81 33.84 8.78 46.25 45.00 2.78
PBDT 74.54 80.05 -6.88 207.99 290.01 -28.28 409.67 265.68 54.20
Depreciation 20.29 19.91 1.91 60.56 60.24 0.53 79.90 72.13 10.77
PBT 54.25 60.14 -9.79 147.43 229.77 -35.84 329.77 193.55 70.38
TAX 14.14 17.16 -17.60 39.91 60.39 -33.91 75.96 61.86 22.79
Deferred Tax -0.86 0.16 -637.50 -2.59 0.39 -764.10 0.36 11.59 -96.89
PAT 40.11 42.98 -6.68 107.52 169.38 -36.52 253.81 131.69 92.73
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 9.60 9.72 -1.21 9.80 9.82 -0.15 9.52 11.94 -20.26

Haleos Labs Share Price

1300.00 1.00 (0.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×